MedTrace Logo

Blood Pressure Assessment in Atrial Fibrillation

NCT01088269 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-09-14

No results posted yet for this study

Summary

This is a cross-sectional study including patients with permanent atrial fibrillation. Assessment will include:

* clinic blood pressure measurements (mercury sphygmomanometer and automated oscillometric device)
* 24-hour ambulatory blood pressure monitoring
* determination of various serum markers and cardiac ultrasound.
* evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG

Conditions

Sponsors & Collaborators

  • University of Athens

    lead OTHER

Principal Investigators

  • George S Stergiou, MD · Hypertension Center,Third Department of Medicine,University of Athens,Greece

Eligibility

Min Age
25 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01088269 on ClinicalTrials.gov